2000
DOI: 10.1021/bi000149n
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Recognition of cAMP by an RNA Aptamer

Abstract: Two classes of RNA aptamers that bind the second messenger adenosine 3',5'-cyclic monophosphate (cAMP; 1) were isolated from a random-sequence pool using in vitro selection. Class I and class II aptamers are formed by 33- and 31-nucleotide RNAs, respectively, and each is comprised of similar stem-loop and single-stranded structural elements. Class II aptamers, which dominate the final selected RNA population, require divalent cations for complex formation and display a dissociation constant (K(D)) for cAMP of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
37
1

Year Published

2004
2004
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(41 citation statements)
references
References 41 publications
3
37
1
Order By: Relevance
“…RzB is thus a logical starting point for the construction of new ribozymes for use in gene knockdown experiments for therapeutic applications or for studies of biological mechanisms. It may also be possible to achieve highly efficient, regulated cleavage by combining these tertiary stabilization motifs into an RNA that also carries modules for allosteric regulation by oligonucleotides (e.g., the TRAP design), by small molecules (e.g., cAMP or theophylline), or by proteins (Koizumi et al 1999;Koizumi and Breaker 2000;Sekella et al 2000;Burke et al 2002;Wang and Sen 2002;Saksmerprome andBurke 2003, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…RzB is thus a logical starting point for the construction of new ribozymes for use in gene knockdown experiments for therapeutic applications or for studies of biological mechanisms. It may also be possible to achieve highly efficient, regulated cleavage by combining these tertiary stabilization motifs into an RNA that also carries modules for allosteric regulation by oligonucleotides (e.g., the TRAP design), by small molecules (e.g., cAMP or theophylline), or by proteins (Koizumi et al 1999;Koizumi and Breaker 2000;Sekella et al 2000;Burke et al 2002;Wang and Sen 2002;Saksmerprome andBurke 2003, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…Aptamers are oligonucleotides that have been selected for specific binding to a variety of molecular targets, ranging from small organics to proteins [20,21]. These nucleic acidbinding species can consist of RNA or DNA and are typically 15-60 nucleotides long [22].…”
Section: Recognition Of Aptamer With Thrombinmentioning
confidence: 99%
“…(1,2) Targets to which aptamers have successfully been generated against include proteins, small molecules and RNA. (3)(4)(5)(6)(7)(8) Aptamers have been suggested as valuable alternatives to antibodies in biodetection and diagnostic applications due to their ease of discovery, their stability, and robust methods for their synthesis. (9)(10)(11)(12) A wealth of sensitive aptamer-based biodetection approaches have been reported in which aptamers were labeled with molecules such as redox probes, fluorescent dyes, or nanocrystals to be an integral part of signal transduction.…”
Section: Introductionmentioning
confidence: 99%